Open access
Open access
Powered by Google Translator Translator

Survey: Despite guideline recommendations, many patients with low-risk thyroid cancer continue to be treated with suppressive doses of thyroid hormone

23 Apr, 2021 | 08:13h | UTC

TSH Suppression for Papillary Thyroid Cancer: A Physician Survey Study – Thyroid (link to abstract – $ for full-text)


Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.